Resmed (Australia) Today
| RMD Stock | 40.50 0.36 0.90% |
Performance9 of 100
| Odds Of DistressLess than 1
|
Resmed is selling for under 40.50 as of the 31st of January 2025; that is 0.90 percent increase since the beginning of the trading day. The stock's last reported lowest price was 40.28. Resmed has a very small chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Resmed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Resmed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Resmed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | BE MBA |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) |
Resmed Inc DRC (RMD) is traded on Australian Securities Exchange in Australia and employs 21 people. Resmed is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 59.6 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Resmed's market, we take the total number of its shares issued and multiply it by Resmed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Resmed Inc DRC operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 1.47 B outstanding shares.
Resmed Inc DRC has accumulated about 273.71 M in cash with 1.4 B of positive cash flow from operations.
Check Resmed Probability Of Bankruptcy
Ownership AllocationResmed owns a total of 1.47 Billion outstanding shares. Roughly 89.51 pct. of Resmed outstanding shares are held by general public with 10.49 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Resmed Ownership Details
Resmed Inc DRC Risk Profiles
Although Resmed's alpha and beta are two of the key measurements used to evaluate Resmed's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.01 | |||
| Semi Deviation | 1.09 | |||
| Standard Deviation | 1.26 | |||
| Variance | 1.59 |
Resmed Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Resmed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Resmed Corporate Management
Elected by the shareholders, the Resmed's board of directors comprises two types of representatives: Resmed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Resmed. The board's role is to monitor Resmed's management team and ensure that shareholders' interests are well served. Resmed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Resmed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Justin Leong | Chief Officer | Profile | |
| Michael Rider | Chief Secretary | Profile | |
| Robert Douglas | Special Advisor | Profile | |
| Vered Keisar | Chief Officer | Profile | |
| Carlos MD | Chief Officer | Profile | |
| Kaushik Ghoshal | Chief SaaS | Profile |
Additional Tools for Resmed Stock Analysis
When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.